SpaceX shares fall 3.5% after Starship abort
SpaceX (NASDAQ:SPCX) shares fell 3.5% to $126.58 premarket after an engine failure aborted Starship’s 13th test before liftoff.
SpaceX (NASDAQ:SPCX) shares fell 3.5% to $126.58 premarket after an engine failure aborted Starship’s 13th test before liftoff.
Veradermics (NYSE:MANE) presented age-based VDPHL01 data from Study ‘302,’ a 519-patient trial in males with mild-to-moderate pattern hair loss.
Solstice Advanced Materials (NASDAQ:SOLS) declared a regular quarterly dividend of $0.075 per common share, payable on September 10, 2026.
Kalaris Therapeutics (NASDAQ:KLRS) reported expanded Phase 1a TH103 data from 20 patients, with plasma exposure up to 53-fold below leading anti-VEGF agents.
ConocoPhillips (NYSE:COP) agreed to acquire a 42% interest in BP’s (NYSE:BP) Kirkuk venture, covering four producing fields and more than 3 billion barrels of oil equivalent.
GSK (NYSE:GSK) ended camlipixant development for chronic cough after CALM-2 missed its primary endpoint at 50mg.
Truist Financial (NYSE:TFC) reported Q2 2026 revenue of $5.23 billion and EPS of $1.08, matching profit expectations but narrowly missing revenue forecasts.
Fifth Third Bancorp (NYSE:FITB) reported Q2 2026 EPS of $0.83 and adjusted EPS of $1.02, supported by organic growth and Comerica integration.
South Plains Financial (NASDAQ:SPFI) reported Q2 net income of $19 million and diluted EPS of $0.96, supported by its BOH acquisition.
Autoliv (NYSE:ALV) reported Q2 net sales of $2.803 billion, up 3.3%, while diluted EPS fell 38% to $1.35.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas